Harpoon: HPN328 Data In 1st Half Of 2024 Makes This A Must Watch [Seeking Alpha]
Harpoon Therapeutics, Inc. (HARP)
Last harpoon therapeutics, inc. earnings: 3/12 04:05 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
Updated data from the phase 1/2 study, using HPN328 for the treatment of patients with neuroendocrine tumors, is expected to be released in the 1st half of 2024. The global neuroendocrine tumors treatment market revenue is expected to increase to $6.33 billion by 2030. PIPE financing agreement brought in $100 million upfront and then possibly $50 million if warrants are exercised; including all of the latest financing, enough cash to fund its operations into 2026. This idea was discussed in more depth with members of my private investing community, Biotech Analysis Central. Learn More » Harpoon Therapeutics NASDAQ: HARP ) has been making great progress in being able to advance its pipeline, that's because it has done well in advancing its drug HPN328 for the treatment of patients with small cell lung cancer [SCLC], neuroendocrine prostate cancer [NEPC] and other neuroendocrine cancers. Such a drug is being advanced in a phase 1/2 study, whereby interim data reported at the ES
Show less
Read more
Impact Snapshot
Event Time:
HARP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HARP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HARP alerts
High impacting Harpoon Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics